Overview of Dr. Cobleigh
Dr. Melody Cobleigh is an oncologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center, Rush Oak Park Hospital, and Loyola University Medical Center. She received her medical degree from Rush Medical College of Rush University Medical Center and has been in practice 42 years. Dr. Cobleigh accepts several types of health insurance, listed below. She is one of 57 doctors at Rush University Medical Center and one of 19 doctors at Rush Oak Park Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
1725 W Harrison St
Suite 1010
Chicago, IL 60612
Education & Training
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1979 - 1981
- Rush University Medical CenterResidency, Internal Medicine, 1977 - 1979
- Rush University Medical CenterResidency, Internal Medicine, 1976 - 1976
- Rush Medical College of Rush University Medical CenterClass of 1975
Certifications & Licensure
- IL State Medical License 1977 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2017
- Chicago Magazine: Top Doctors Castle Connolly, 2004, 2006, 2008, 2010, 2012, 2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer Start of enrollment: 1995 Oct 01
- Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer Start of enrollment: 2000 Nov 28
- Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer Start of enrollment: 2002 Jan 29
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsEganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, ...Brenda C O'Connell, Charley Hubbard, Nora Zizlsperger, Donna Fitzgerald, Jeffrey L Kutok
Journal for Immunotherapy of Cancer. 2024-08-30 - 3 citationsComparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.Melody A Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J Hockenberry
Breast Cancer Research and Treatment. 2024-04-01 - Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.Jian Chu, Lillian Tung, Issam Atallah, Changli Wei, Melody Cobleigh
Cardio-Oncology. 2024-02-06
Journal Articles
- Can Chimerism Explain breast/ovarian Cancers in BRCA Non-Carriers from BRCA-Positive Families?Lydia Usha, Melody Cobleigh, PLoS One
Press Mentions
- Dr. Janet Wolter, Oncologist and Cancer Researcher at Rush, DiesFebruary 9th, 2020
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: